Trevi Therapeutics, Inc. (TRVI) Financials
TRVI Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | 89.4 million | 6.9 million |
2023-09-30 | 95.9 million | 6.3 million |
2023-06-30 | 101.0 million | 5.9 million |
2023-03-31 | 116.2 million | 14.5 million |
TRVI Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | -6.4 million | 534000 |
2023-09-30 | -7.3 million | 530000 |
2023-06-30 | -9.9 million | 605000 |
2023-03-31 | -8.3 million | 578000 |
TRVI Net Income
No data available :(
TRVI Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | - | - | 1.3 million |
2023-09-30 | 88.9 million | - | 1.4 million |
2023-06-30 | 94.2 million | - | 1.5 million |
2023-03-31 | 11.7 million | - | 1.5 million |
TRVI Shares Outstanding
TRVI Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | 22000 | 6.5 million | 2.4 million | - |
2023-09-30 | 18000 | 6.3 million | 2.7 million | - |
2023-06-30 | 40000 | 5.8 million | 2.5 million | - |
2023-03-31 | 57000 | 5.0 million | 2.6 million | - |
TRVI Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | - | - |
2023-09-30 | - | 35000 |
2023-06-30 | - | 34000 |
2023-03-31 | - | 19000 |
TRVI
Price: $3.02
52 week price:
Earnings Per Share: -0.29 USD
P/E Ratio: -7.45
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Volume: 28000
Market Capitalization: 201.4 million